Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

Olsen, O E ; Wader, K F ; Misund, K ; Våtsveen, T K ; Rø, T B ; Mylin, A K ; Turesson, Ingemar LU ; Størdal, B F ; Moen, S H and Standal, T , et al. (2014) In Blood Cancer Journal 4(Mar 21). p.196-196
Abstract
Multiple myeloma is a malignancy of plasma cells predominantly located in the bone marrow. A number of bone morphogenetic proteins (BMPs) induce apoptosis in myeloma cells in vitro, and with this study we add BMP-9 to the list. BMP-9 has been found in human serum at concentrations that inhibit cancer cell growth in vitro. We here show that the level of BMP-9 in serum was elevated in myeloma patients (median 176 pg/ml, range 8-809) compared with healthy controls (median 110 pg/ml, range 8-359). BMP-9 was also present in the bone marrow and was able to induce apoptosis in 4 out of 11 primary myeloma cell samples by signaling through ALK2. BMP-9-induced apoptosis in myeloma cells was associated with c-MYC downregulation. The effects of BMP-9... (More)
Multiple myeloma is a malignancy of plasma cells predominantly located in the bone marrow. A number of bone morphogenetic proteins (BMPs) induce apoptosis in myeloma cells in vitro, and with this study we add BMP-9 to the list. BMP-9 has been found in human serum at concentrations that inhibit cancer cell growth in vitro. We here show that the level of BMP-9 in serum was elevated in myeloma patients (median 176 pg/ml, range 8-809) compared with healthy controls (median 110 pg/ml, range 8-359). BMP-9 was also present in the bone marrow and was able to induce apoptosis in 4 out of 11 primary myeloma cell samples by signaling through ALK2. BMP-9-induced apoptosis in myeloma cells was associated with c-MYC downregulation. The effects of BMP-9 were counteracted by membrane-bound (CD105) or soluble endoglin present in the bone marrow microenvironment, suggesting a mechanism for how myeloma cells can evade the tumor suppressing activity of BMP-9 in multiple myeloma. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood Cancer Journal
volume
4
issue
Mar 21
pages
196 - 196
publisher
Nature Publishing Group
external identifiers
  • pmid:24658374
  • wos:000334494800008
  • scopus:84901840766
  • pmid:24658374
ISSN
2044-5385
DOI
10.1038/bcj.2014.16
language
English
LU publication?
yes
id
5ea4548b-0431-4702-9353-38f4ec17b6ed (old id 4379870)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24658374?dopt=Abstract
date added to LUP
2016-04-01 13:31:35
date last changed
2022-02-04 07:57:40
@article{5ea4548b-0431-4702-9353-38f4ec17b6ed,
  abstract     = {{Multiple myeloma is a malignancy of plasma cells predominantly located in the bone marrow. A number of bone morphogenetic proteins (BMPs) induce apoptosis in myeloma cells in vitro, and with this study we add BMP-9 to the list. BMP-9 has been found in human serum at concentrations that inhibit cancer cell growth in vitro. We here show that the level of BMP-9 in serum was elevated in myeloma patients (median 176 pg/ml, range 8-809) compared with healthy controls (median 110 pg/ml, range 8-359). BMP-9 was also present in the bone marrow and was able to induce apoptosis in 4 out of 11 primary myeloma cell samples by signaling through ALK2. BMP-9-induced apoptosis in myeloma cells was associated with c-MYC downregulation. The effects of BMP-9 were counteracted by membrane-bound (CD105) or soluble endoglin present in the bone marrow microenvironment, suggesting a mechanism for how myeloma cells can evade the tumor suppressing activity of BMP-9 in multiple myeloma.}},
  author       = {{Olsen, O E and Wader, K F and Misund, K and Våtsveen, T K and Rø, T B and Mylin, A K and Turesson, Ingemar and Størdal, B F and Moen, S H and Standal, T and Waage, A and Sundan, A and Holien, T}},
  issn         = {{2044-5385}},
  language     = {{eng}},
  number       = {{Mar 21}},
  pages        = {{196--196}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Blood Cancer Journal}},
  title        = {{Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.}},
  url          = {{https://lup.lub.lu.se/search/files/3427928/4646201}},
  doi          = {{10.1038/bcj.2014.16}},
  volume       = {{4}},
  year         = {{2014}},
}